San Diego, CA, United States of America

Kristen R Taylor Meadows

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Receptos, Inc.. Active years: 2021-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristen R Taylor Meadows. Retrieved from https://idiyas.com/inventor/kristen-r-taylor-meadows

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kristen R Taylor Meadows: Innovator in Lupus Treatment and Neuroprotection

Introduction

Kristen R Taylor Meadows is a prominent inventor based in San Diego, CA, known for her significant contributions to medical research and innovation. With a focus on developing treatments for systemic lupus erythematosus and neuroprotection, she has been awarded two patents that highlight her expertise in the field.

Latest Patents

Her latest patents include "Compounds and methods for treating lupus," which details methods for the treatment of systemic lupus erythematosus (SLE) through the administration of a modulator of sphingosine-1-phosphate receptor subtype 1 (S1P1). This patent outlines the general structure of S1P1 modulators and their potential applications. Another notable patent is "Sphingosine 1 phosphate receptor agonists for neuroprotection," which describes methods for treating conditions that require S1P-mediated neuroprotection. This involves administering an agonist of the sphingosine 1-phosphate receptor to individuals in need, showcasing her innovative approach to medical treatment.

Career Highlights

Kristen is currently associated with Receptos, Inc., where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the medical community, particularly in the areas of autoimmune diseases and neuroprotection.

Collaborations

Throughout her

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…